JP2005068010A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005068010A5 JP2005068010A5 JP2003063378A JP2003063378A JP2005068010A5 JP 2005068010 A5 JP2005068010 A5 JP 2005068010A5 JP 2003063378 A JP2003063378 A JP 2003063378A JP 2003063378 A JP2003063378 A JP 2003063378A JP 2005068010 A5 JP2005068010 A5 JP 2005068010A5
- Authority
- JP
- Japan
- Prior art keywords
- risedronate
- pharmaceutical composition
- unit dose
- composition according
- mammal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5335197P | 1997-07-22 | 1997-07-22 | |
| US5353597P | 1997-07-23 | 1997-07-23 | |
| GBGB9717590.5A GB9717590D0 (en) | 1997-08-20 | 1997-08-20 | Oral method for treating or preventing abnormal bone resorption |
| GBGB9717850.3A GB9717850D0 (en) | 1997-08-22 | 1997-08-22 | Oral method for treating or preventing abnormal bone resorption |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP50991499A Division JP3479780B2 (ja) | 1997-07-22 | 1998-07-17 | 骨吸収を抑制する方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005068010A JP2005068010A (ja) | 2005-03-17 |
| JP2005068010A5 true JP2005068010A5 (enExample) | 2005-06-16 |
Family
ID=27451690
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP50991499A Expired - Lifetime JP3479780B2 (ja) | 1997-07-22 | 1998-07-17 | 骨吸収を抑制する方法 |
| JP2003063378A Pending JP2005068010A (ja) | 1997-07-22 | 2003-03-10 | 骨吸収を抑制する方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP50991499A Expired - Lifetime JP3479780B2 (ja) | 1997-07-22 | 1998-07-17 | 骨吸収を抑制する方法 |
Country Status (31)
| Country | Link |
|---|---|
| EP (5) | EP1151752A3 (enExample) |
| JP (2) | JP3479780B2 (enExample) |
| KR (3) | KR20030097610A (enExample) |
| CN (3) | CN1299689C (enExample) |
| AT (2) | ATE357921T1 (enExample) |
| AU (1) | AU8493698A (enExample) |
| BG (1) | BG66282B1 (enExample) |
| BR (1) | BR9810779A (enExample) |
| CA (1) | CA2294595C (enExample) |
| CY (2) | CY1107535T1 (enExample) |
| DE (6) | DE69803291T2 (enExample) |
| DK (2) | DK0998292T3 (enExample) |
| EA (1) | EA004544B2 (enExample) |
| EE (1) | EE05603B1 (enExample) |
| ES (3) | ES2269014T3 (enExample) |
| HK (4) | HK1042230A1 (enExample) |
| ID (1) | ID24096A (enExample) |
| IL (1) | IL133535A0 (enExample) |
| IS (3) | IS5315A (enExample) |
| LU (2) | LU91222I2 (enExample) |
| NL (2) | NL300223I1 (enExample) |
| NO (1) | NO20000323L (enExample) |
| NZ (1) | NZ501807A (enExample) |
| PL (1) | PL195272B1 (enExample) |
| PT (2) | PT1175904E (enExample) |
| SG (2) | SG139556A1 (enExample) |
| SI (1) | SI0998292T1 (enExample) |
| SK (1) | SK932000A3 (enExample) |
| TR (1) | TR200000145T2 (enExample) |
| UY (1) | UY25950A1 (enExample) |
| WO (1) | WO1999004773A2 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE263566T1 (de) | 1998-12-25 | 2004-04-15 | Yamanouchi Pharma Co Ltd | Medizinische zusammensetzungen zur behandlung von knochenschäden im multiplen myelom |
| SK16682001A3 (sk) * | 1999-05-21 | 2002-04-04 | Novartis Ag | Liečivo na liečenie angiogenézy |
| CA2344313C (en) * | 1999-07-19 | 2007-11-27 | Toray Industries, Inc. | Agents for periodontal disease |
| US20010044427A1 (en) * | 1999-12-20 | 2001-11-22 | Sidney Mazel | Pharmaceutical kit |
| US6978894B2 (en) | 1999-12-20 | 2005-12-27 | Merck & Co., Inc. | Blister package for pharmaceutical treatment card |
| CA2405360A1 (en) * | 2000-04-07 | 2001-10-18 | The Board Of Regents Of The University Of Texas System | Unique compositions of zwitterionic phospholipids and bisphosphonates and use of the compositions as bisphosphate delivery systems with reduced gi toxicity |
| SK287278B6 (sk) | 2000-06-20 | 2010-05-07 | Novartis Ag | Použitie kyseliny 1-hydroxy-2-(imidazol-1-yl)etán-1,1- difosfónovej na prípravu liečiva na liečenie stavov abnormálne zvýšeného kostného obratu |
| SI1591122T1 (sl) * | 2000-06-20 | 2013-02-28 | Novartis Ag | Postopek za aplikacijo bisfosfonatov |
| US6638920B2 (en) * | 2000-07-21 | 2003-10-28 | Merck & Co., Inc. | Compositions and methods of preventing or reducing the risk or incidence of skeletal injuries in horses |
| SE0101379D0 (sv) | 2001-04-18 | 2001-04-18 | Diabact Ab | Komposition som hämmar utsöndring av magsyra |
| CA2444718A1 (en) * | 2001-05-02 | 2002-11-14 | Novartis Ag | Method of administration of bisphosphonates by inhalation in the treatment or prevention of bone resorption and osteoporosis |
| CA2763775C (en) * | 2002-05-10 | 2014-01-07 | F. Hoffmann-La Roche Ag | Bisphosphonic acids for the treatment and prevention of osteoporosis |
| SE0203065D0 (sv) | 2002-10-16 | 2002-10-16 | Diabact Ab | Gastric acid secretion inhibiting composition |
| MXPA06003063A (es) * | 2003-09-19 | 2006-05-31 | Pfizer Prod Inc | Composiciones farmaceuticas y metodos que comprenden combinaciones de derivados de 2-alquiliden-19-nor-vitamina- d y un bisfosfonato. |
| WO2005072747A1 (ja) * | 2004-02-02 | 2005-08-11 | Ono Pharmaceutical Co., Ltd. | 骨吸収抑制剤 |
| BRPI0615770A2 (pt) * | 2005-09-16 | 2011-05-24 | Selamine Ltd | formulação de bisfosfonato |
| ES2716525T3 (es) * | 2010-12-06 | 2019-06-13 | Effrx Pharmaceuticals Sa | Formulaciones de bisfosfonatos efervescentes estables con características de solubilización rápida |
| CN106924257B (zh) * | 2017-03-14 | 2019-11-19 | 湖南赛隆药业有限公司 | 质子泵抑制剂和抗骨质疏松药的复合物及其用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL84731A0 (en) * | 1986-12-19 | 1988-05-31 | Norwich Eaton Pharma | Heterocycle-substituted diphosphonic acids and salts and esters and pharmaceutical compositions containing them |
| SE8704436D0 (sv) * | 1987-11-13 | 1987-11-13 | Pm Konsult Handelsbolag | Anvendning av antisekretoriska substanser for nya indikationer |
| ATE122228T1 (de) * | 1991-07-01 | 1995-05-15 | Gergely Gerhard | Verfahren zur herstellung einer pharmazeutischen zubereitung mit wenigstens zwei verschiedenen wirkstoffen und verwendung einer solchen zubereitung. |
| CZ282760B6 (cs) * | 1991-11-22 | 1997-09-17 | Procter And Gamble Pharmaceuticals, Inc. | Risedronátové prostředky se zpožděným uvolňováním |
| US5270365A (en) * | 1991-12-17 | 1993-12-14 | Merck & Co., Inc. | Prevention and treatment of periodontal disease with alendronate |
| US5294433A (en) * | 1992-04-15 | 1994-03-15 | The Procter & Gamble Company | Use of H-2 antagonists for treatment of gingivitis |
| EP0648120B1 (en) * | 1992-06-30 | 1997-12-29 | PROCTER & GAMBLE PHARMACEUTICALS, INC. | Use of phosphonates for the treatment of osteoporosis |
| US5431920A (en) * | 1993-09-21 | 1995-07-11 | Merck Frosst, Canada, Inc. | Enteric coated oral compositions containing bisphosphonic acid antihypercalcemic agents |
| US5646134A (en) * | 1994-04-21 | 1997-07-08 | Merck & Co., Inc. | Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices |
| EP0831843A1 (en) * | 1995-06-06 | 1998-04-01 | Merck & Co., Inc. | Bisphosphonate therapy for bone loss associated with rheumatoid arthritis |
| JP2000511178A (ja) * | 1996-05-17 | 2000-08-29 | メルク エンド カンパニー インコーポレーテッド | 発泡性ビスホスホネート製剤 |
-
1998
- 1998-07-17 ES ES01201913T patent/ES2269014T3/es not_active Expired - Lifetime
- 1998-07-17 KR KR1020027013594A patent/KR20030097610A/ko not_active Ceased
- 1998-07-17 EE EEP200000040A patent/EE05603B1/xx unknown
- 1998-07-17 KR KR1020007000680A patent/KR100391732B1/ko not_active Expired - Fee Related
- 1998-07-17 CN CNB2004100557350A patent/CN1299689C/zh not_active Expired - Lifetime
- 1998-07-17 DE DE69803291T patent/DE69803291T2/de not_active Revoked
- 1998-07-17 DK DK98935752T patent/DK0998292T3/da active
- 1998-07-17 CA CA002294595A patent/CA2294595C/en not_active Expired - Fee Related
- 1998-07-17 SG SG200603406-0A patent/SG139556A1/en unknown
- 1998-07-17 AT AT01201913T patent/ATE357921T1/de active
- 1998-07-17 EA EA200000151A patent/EA004544B2/ru not_active IP Right Cessation
- 1998-07-17 KR KR1020027013595A patent/KR20030097611A/ko not_active Ceased
- 1998-07-17 CN CNB988074737A patent/CN1166365C/zh not_active Ceased
- 1998-07-17 DE DE1998603291 patent/DE122006000009I1/de active Pending
- 1998-07-17 PT PT01201913T patent/PT1175904E/pt unknown
- 1998-07-17 AT AT98935752T patent/ATE209037T1/de active
- 1998-07-17 EP EP01201911A patent/EP1151752A3/en not_active Ceased
- 1998-07-17 TR TR2000/00145T patent/TR200000145T2/xx unknown
- 1998-07-17 DE DE01201913T patent/DE01201913T1/de active Pending
- 1998-07-17 NZ NZ501807A patent/NZ501807A/en not_active IP Right Cessation
- 1998-07-17 SG SG200107221A patent/SG109478A1/en unknown
- 1998-07-17 ES ES01201910T patent/ES2253136T1/es active Pending
- 1998-07-17 AU AU84936/98A patent/AU8493698A/en not_active Abandoned
- 1998-07-17 SK SK93-2000A patent/SK932000A3/sk not_active Application Discontinuation
- 1998-07-17 IL IL13353598A patent/IL133535A0/xx unknown
- 1998-07-17 DE DE200712000063 patent/DE122007000063I1/de active Pending
- 1998-07-17 CN CNA2004100557346A patent/CN1602879A/zh active Pending
- 1998-07-17 ID IDW20000114A patent/ID24096A/id unknown
- 1998-07-17 WO PCT/US1998/014796 patent/WO1999004773A2/en not_active Ceased
- 1998-07-17 DE DE01201911T patent/DE01201911T1/de active Pending
- 1998-07-17 PL PL98338635A patent/PL195272B1/pl unknown
- 1998-07-17 PT PT98935752T patent/PT998292E/pt unknown
- 1998-07-17 EP EP01201910A patent/EP1132088A3/en not_active Ceased
- 1998-07-17 DE DE69837450T patent/DE69837450T2/de not_active Expired - Lifetime
- 1998-07-17 EP EP98935752A patent/EP0998292B1/en not_active Revoked
- 1998-07-17 DK DK01201913T patent/DK1175904T3/da active
- 1998-07-17 BR BR9810779-8A patent/BR9810779A/pt not_active Application Discontinuation
- 1998-07-17 EP EP01201912A patent/EP1175903A3/en not_active Ceased
- 1998-07-17 JP JP50991499A patent/JP3479780B2/ja not_active Expired - Lifetime
- 1998-07-17 ES ES98935752T patent/ES2164447T3/es not_active Expired - Lifetime
- 1998-07-17 SI SI9830086T patent/SI0998292T1/xx unknown
- 1998-07-17 EP EP01201913A patent/EP1175904B8/en not_active Revoked
-
1999
- 1999-12-21 IS IS5315A patent/IS5315A/is unknown
-
2000
- 2000-01-17 UY UY25950A patent/UY25950A1/es not_active Application Discontinuation
- 2000-01-18 BG BG104093A patent/BG66282B1/bg unknown
- 2000-01-21 NO NO20000323A patent/NO20000323L/no unknown
-
2002
- 2002-03-04 HK HK02101656.1A patent/HK1042230A1/en unknown
- 2002-03-12 HK HK02101869.4A patent/HK1042232A1/en unknown
- 2002-03-16 HK HK02102043.1A patent/HK1040495A1/en unknown
- 2002-03-16 HK HK02102042.2A patent/HK1040494A1/en unknown
-
2003
- 2003-03-10 JP JP2003063378A patent/JP2005068010A/ja active Pending
-
2004
- 2004-04-21 IS IS7231A patent/IS7231A/is unknown
- 2004-04-21 IS IS7230A patent/IS7230A/is unknown
-
2006
- 2006-02-07 NL NL300223C patent/NL300223I1/nl unknown
- 2006-02-15 LU LU91222C patent/LU91222I2/fr unknown
-
2007
- 2007-03-29 CY CY20071100442T patent/CY1107535T1/el unknown
- 2007-09-12 LU LU91364C patent/LU91364I2/fr unknown
- 2007-09-13 NL NL300292C patent/NL300292I1/nl unknown
- 2007-09-20 CY CY2007022C patent/CY2007022I1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005068010A5 (enExample) | ||
| JP2006504795A5 (enExample) | ||
| ES2247123T3 (es) | Metodo para administrar bisfosfonatos. | |
| HRP20130057T1 (hr) | Lijeäśenje progresivne neurodegenerativne bolesti ibudilastom | |
| JP2013121983A5 (enExample) | ||
| HRP20161444T1 (hr) | Farmaceutski pripravci koji sadrže lokalni anestetik kao što je bupivakain za lokalnu primjenu u usta ili grlo | |
| CA2434484A1 (en) | Compositions comprising ibuprofen and diphenhydramine to treat pain-associated sleep disturbances | |
| ATE350040T1 (de) | Stabilisierte pharmazeutische zusammensetzung enthaltend einen nichtsteroiden entzündungshemmenden wirkstoff und prostaglandin | |
| JP2002509888A5 (enExample) | ||
| IL205262A (en) | Use of Risderdone Acid or its Pharmaceutical Salt to produce oral medication once a month for the prevention and treatment of osteoporosis | |
| EA200700049A1 (ru) | Препаративные формы оральных лекарственных форм мемантина с модифицированным высвобождением | |
| JP2013231087A5 (enExample) | ||
| ATE424810T1 (de) | Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung | |
| FR2878161B1 (fr) | Forme medicamenteuse orale, solide et concue pour eviter le mesusage | |
| WO2006029036A3 (en) | Combination therapy with glatiramer acetate and n-acetylcysteine for the treatment of multiple sclerosis | |
| HRP20100276T1 (hr) | Gaboksadol za liječenje depresije i drugih afektivnih poremećaja | |
| ATE543491T1 (de) | Kombinationspräparat enthaltend ibuprofen und paracetamol | |
| RU2007103306A (ru) | Композиции на основе ризедроната и способы их применения | |
| JPH10147529A5 (enExample) | ||
| JP2005519936A5 (enExample) | ||
| RU2005105691A (ru) | Пероральное введение кальцитонина | |
| MXPA04004907A (es) | Composiciones de acetaminofen. | |
| JP2002540148A5 (enExample) | ||
| RU2006131553A (ru) | Комбинация(а) ингибитора топоизомеразы днк и (б) ингибитора iap | |
| HRP20211661T1 (hr) | Igmezin, namijenjen upotrebi u liječenju alzheimerove bolesti |